Mah, S.M.; Sid’Ahmed, S.; Lemrabott, M.; Welli, D.; Awa, J.; Sidi Aly, A.; Rostaing, L.
The Effectiveness of a Sofosbuvir/Daclatasvir Combination in the Treatment of HCV Infection in Patients from Mauritania Undergoing Chronic Hemodialysis. Medicina 2025, 61, 1753.
https://doi.org/10.3390/medicina61101753
AMA Style
Mah SM, Sid’Ahmed S, Lemrabott M, Welli D, Awa J, Sidi Aly A, Rostaing L.
The Effectiveness of a Sofosbuvir/Daclatasvir Combination in the Treatment of HCV Infection in Patients from Mauritania Undergoing Chronic Hemodialysis. Medicina. 2025; 61(10):1753.
https://doi.org/10.3390/medicina61101753
Chicago/Turabian Style
Mah, Sidi Mohamed, Soufiane Sid’Ahmed, Mohamed Lemrabott, Delahi Welli, Jemal Awa, Abdellatif Sidi Aly, and Lionel Rostaing.
2025. "The Effectiveness of a Sofosbuvir/Daclatasvir Combination in the Treatment of HCV Infection in Patients from Mauritania Undergoing Chronic Hemodialysis" Medicina 61, no. 10: 1753.
https://doi.org/10.3390/medicina61101753
APA Style
Mah, S. M., Sid’Ahmed, S., Lemrabott, M., Welli, D., Awa, J., Sidi Aly, A., & Rostaing, L.
(2025). The Effectiveness of a Sofosbuvir/Daclatasvir Combination in the Treatment of HCV Infection in Patients from Mauritania Undergoing Chronic Hemodialysis. Medicina, 61(10), 1753.
https://doi.org/10.3390/medicina61101753
